hope rugo, md, examines data from the destiny-breast01 clinical study presented at sabcs 2020
Published 3 years ago • 194 plays • Length 3:31
Download video MP4
Download video MP3
Similar videos
-
4:54
hope rugo, md, shares the design and outcomes of keynote-355 presented at sabcs 2020
-
2:29
adam brufsky, md, phd, elaborates on the clinical implications of destiny-breast01 from sabcs 2020
-
1:42
hope rugo, md, offers key takeaways for physicians regarding keynote-355
-
4:50
hope rugo, md, provides perspective on the clinical progress of cdk 4/6 inhibitors in breast cancer
-
1:26
hope rugo, md, considers chemotherapy recommendations based on findings from keynote-355
-
9:37
hope rugo, md: clinical updates from sabcs 2012
-
48:01
metastatic her2-positive and triple-negative bc | annual national general medical oncology summit
-
3:23
ucsf at #aacr24: hope rugo, md | clinical trials discussant on "advanced in targeted therapy"
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
56:48
bcna webcast- global insights and local voices on metastatic breast cancer
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
2:02
hope rugo, md, considers the incidence of tnbc and what makes this disease so difficult to treat
-
1:53
dr. hope rugo examines angiogenesis inhibition for advanced breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
4:15
hope rugo, md, fasco at #asco23
-
1:29:07
2021 sabcs what changes monday morning? her2 breast cancer panel discussion
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
1:00:31
inspired | beyond the white coat with dr. hope rugo
-
2:38
at asco 2019, dr. hope rugo presents on results of the sophia breast cancer study
-
42:30
7 dr hope rugo
-
12:18
hope rugo, md: breast cancer data highlights from emcc 2011
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
Clip.africa.com - Privacy-policy